Chris Gale, Dusha Jeyakumaran, Nicholas Longford, Cheryl Battersby, Shalini Ojha, Kayleigh Oughham, Jon Dorling
Journal: Archives of disease in childhood. Fetal and neonatal edition 2021;106(6):608-613
PMID: 33952628
BACKGROUND
Parenteral nutrition is commonly administered during therapeutic hypothermia. Randomised trials in critically ill children indicate that parenteral nutrition may be harmful.
OBJECTIVE
To examine the association between parenteral nutrition during therapeutic hypothermia and clinically important outcomes.
DESIGN
Retrospective, population-based cohort study using the National Neonatal Research Database; propensity scores were used to create matched groups for comparison.
SETTING
National Health Service neonatal units in England, Scotland and Wales.
PARTICIPANTS
6030 term and near-term babies, born 1/1/2010 and 31/12/2017, who received therapeutic hypothermia; 2480 babies in the matched analysis.
EXPOSURE
We compared babies that received any parenteral nutrition during therapeutic hypothermia with babies that did not.
MAIN OUTCOME MEASURES
Primary outcome: blood culture confirmed late-onset infection; secondary outcomes: treatment for late onset infection, necrotising enterocolitis, survival, length of stay, measures of breast feeding, hypoglycaemia, central line days, time to full enteral feeds, discharge weight.
RESULTS
1475/6030 babies (25%) received parenteral nutrition. In comparative matched analyses, the rate of culture positive late onset infection was higher in babies that received parenteral nutrition (0.3% vs 0.9%; difference 0.6; 95% CI 0.1, 1.2; p=0.03), but treatment for presumed infection was not (difference 0.8%, 95% CI -2.1 to 3.6, p=0.61). Survival was higher in babies that received parenteral nutrition (93.1% vs 90.0%; rate difference 3.1, 95% CI 1.5, 4.7; p<0.001).
CONCLUSIONS
Receipt of parenteral nutrition during therapeutic hypothermia is associated with higher late-onset infection but lower mortality. This finding may be explained by residual confounding. Research should address the risks and benefits of parenteral nutrition in this population.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.